The global Breath Molecular Diagnostic Device market size is projected to grow from US$ 257 million in 2024 to US$ 520 million in 2030; it is expected to grow at a CAGR of 12.4% from 2024 to 2030.
The 鈥淏reath Molecular Diagnostic Device Industry Forecast鈥� looks at past sales and reviews total world Breath Molecular Diagnostic Device sales in 2023, providing a comprehensive analysis by region and market sector of projected Breath Molecular Diagnostic Device sales for 2024 through 2030. With Breath Molecular Diagnostic Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Breath Molecular Diagnostic Device industry.
This Insight Report provides a comprehensive analysis of the global Breath Molecular Diagnostic Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Breath Molecular Diagnostic Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Breath Molecular Diagnostic Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Breath Molecular Diagnostic Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Breath Molecular Diagnostic Device.
United States market for Breath Molecular Diagnostic Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Breath Molecular Diagnostic Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Breath Molecular Diagnostic Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Breath Molecular Diagnostic Device players cover NIOX Group plc, Headway, Sunvou Medical Electronics Co, CAIRE (NGK), Richen Holding, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Breath Molecular Diagnostic Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
C13 Type
NO Type
H2/CO Type
VOCs Type
Segmentation by Application:
Hospital
Clinic
Physical Examination Center
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
NIOX Group plc
Headway
Sunvou Medical Electronics Co
CAIRE (NGK)
Richen Holding
Meridian Bioscience
CAPNIA, Inc.
碍颈产颈辞苍鈥嬧赌�
Otsuka Electronics
LEYI BIOLOGY
Eco Physics AG
Shenzhen Breax
QUINTRON
Beijing Wanliandaxinke Instruments Co
SIMES SIKMA
Beijing Safe Heart Technology
e-LinkCare Meditech Co
ChromX Health
Huiyuen Tech
Owlstone Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Breath Molecular Diagnostic Device market?
What factors are driving Breath Molecular Diagnostic Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Breath Molecular Diagnostic Device market opportunities vary by end market size?
How does Breath Molecular Diagnostic Device break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Breath Molecular Diagnostic Device Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Breath Molecular Diagnostic Device by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Breath Molecular Diagnostic Device by Country/Region, 2019, 2023 & 2030
2.2 Breath Molecular Diagnostic Device Segment by Type
2.2.1 C13 Type
2.2.2 NO Type
2.2.3 H2/CO Type
2.2.4 VOCs Type
2.3 Breath Molecular Diagnostic Device Sales by Type
2.3.1 Global Breath Molecular Diagnostic Device Sales Market Share by Type (2019-2024)
2.3.2 Global Breath Molecular Diagnostic Device Revenue and Market Share by Type (2019-2024)
2.3.3 Global Breath Molecular Diagnostic Device Sale Price by Type (2019-2024)
2.4 Breath Molecular Diagnostic Device Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Physical Examination Center
2.4.4 Other
2.5 Breath Molecular Diagnostic Device Sales by Application
2.5.1 Global Breath Molecular Diagnostic Device Sale Market Share by Application (2019-2024)
2.5.2 Global Breath Molecular Diagnostic Device Revenue and Market Share by Application (2019-2024)
2.5.3 Global Breath Molecular Diagnostic Device Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Breath Molecular Diagnostic Device Breakdown Data by Company
3.1.1 Global Breath Molecular Diagnostic Device Annual Sales by Company (2019-2024)
3.1.2 Global Breath Molecular Diagnostic Device Sales Market Share by Company (2019-2024)
3.2 Global Breath Molecular Diagnostic Device Annual Revenue by Company (2019-2024)
3.2.1 Global Breath Molecular Diagnostic Device Revenue by Company (2019-2024)
3.2.2 Global Breath Molecular Diagnostic Device Revenue Market Share by Company (2019-2024)
3.3 Global Breath Molecular Diagnostic Device Sale Price by Company
3.4 Key Manufacturers Breath Molecular Diagnostic Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Breath Molecular Diagnostic Device Product Location Distribution
3.4.2 Players Breath Molecular Diagnostic Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Breath Molecular Diagnostic Device by Geographic Region
4.1 World Historic Breath Molecular Diagnostic Device Market Size by Geographic Region (2019-2024)
4.1.1 Global Breath Molecular Diagnostic Device Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Breath Molecular Diagnostic Device Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Breath Molecular Diagnostic Device Market Size by Country/Region (2019-2024)
4.2.1 Global Breath Molecular Diagnostic Device Annual Sales by Country/Region (2019-2024)
4.2.2 Global Breath Molecular Diagnostic Device Annual Revenue by Country/Region (2019-2024)
4.3 Americas Breath Molecular Diagnostic Device Sales Growth
4.4 APAC Breath Molecular Diagnostic Device Sales Growth
4.5 Europe Breath Molecular Diagnostic Device Sales Growth
4.6 Middle East & Africa Breath Molecular Diagnostic Device Sales Growth
5 Americas
5.1 Americas Breath Molecular Diagnostic Device Sales by Country
5.1.1 Americas Breath Molecular Diagnostic Device Sales by Country (2019-2024)
5.1.2 Americas Breath Molecular Diagnostic Device Revenue by Country (2019-2024)
5.2 Americas Breath Molecular Diagnostic Device Sales by Type (2019-2024)
5.3 Americas Breath Molecular Diagnostic Device Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Breath Molecular Diagnostic Device Sales by Region
6.1.1 APAC Breath Molecular Diagnostic Device Sales by Region (2019-2024)
6.1.2 APAC Breath Molecular Diagnostic Device Revenue by Region (2019-2024)
6.2 APAC Breath Molecular Diagnostic Device Sales by Type (2019-2024)
6.3 APAC Breath Molecular Diagnostic Device Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Breath Molecular Diagnostic Device by Country
7.1.1 Europe Breath Molecular Diagnostic Device Sales by Country (2019-2024)
7.1.2 Europe Breath Molecular Diagnostic Device Revenue by Country (2019-2024)
7.2 Europe Breath Molecular Diagnostic Device Sales by Type (2019-2024)
7.3 Europe Breath Molecular Diagnostic Device Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Breath Molecular Diagnostic Device by Country
8.1.1 Middle East & Africa Breath Molecular Diagnostic Device Sales by Country (2019-2024)
8.1.2 Middle East & Africa Breath Molecular Diagnostic Device Revenue by Country (2019-2024)
8.2 Middle East & Africa Breath Molecular Diagnostic Device Sales by Type (2019-2024)
8.3 Middle East & Africa Breath Molecular Diagnostic Device Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Breath Molecular Diagnostic Device
10.3 Manufacturing Process Analysis of Breath Molecular Diagnostic Device
10.4 Industry Chain Structure of Breath Molecular Diagnostic Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Breath Molecular Diagnostic Device Distributors
11.3 Breath Molecular Diagnostic Device Customer
12 World Forecast Review for Breath Molecular Diagnostic Device by Geographic Region
12.1 Global Breath Molecular Diagnostic Device Market Size Forecast by Region
12.1.1 Global Breath Molecular Diagnostic Device Forecast by Region (2025-2030)
12.1.2 Global Breath Molecular Diagnostic Device Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Breath Molecular Diagnostic Device Forecast by Type (2025-2030)
12.7 Global Breath Molecular Diagnostic Device Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 NIOX Group plc
13.1.1 NIOX Group plc Company Information
13.1.2 NIOX Group plc Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.1.3 NIOX Group plc Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 NIOX Group plc Main Business Overview
13.1.5 NIOX Group plc Latest Developments
13.2 Headway
13.2.1 Headway Company Information
13.2.2 Headway Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.2.3 Headway Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Headway Main Business Overview
13.2.5 Headway Latest Developments
13.3 Sunvou Medical Electronics Co
13.3.1 Sunvou Medical Electronics Co Company Information
13.3.2 Sunvou Medical Electronics Co Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.3.3 Sunvou Medical Electronics Co Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sunvou Medical Electronics Co Main Business Overview
13.3.5 Sunvou Medical Electronics Co Latest Developments
13.4 CAIRE (NGK)
13.4.1 CAIRE (NGK) Company Information
13.4.2 CAIRE (NGK) Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.4.3 CAIRE (NGK) Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 CAIRE (NGK) Main Business Overview
13.4.5 CAIRE (NGK) Latest Developments
13.5 Richen Holding
13.5.1 Richen Holding Company Information
13.5.2 Richen Holding Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.5.3 Richen Holding Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Richen Holding Main Business Overview
13.5.5 Richen Holding Latest Developments
13.6 Meridian Bioscience
13.6.1 Meridian Bioscience Company Information
13.6.2 Meridian Bioscience Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.6.3 Meridian Bioscience Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Meridian Bioscience Main Business Overview
13.6.5 Meridian Bioscience Latest Developments
13.7 CAPNIA, Inc.
13.7.1 CAPNIA, Inc. Company Information
13.7.2 CAPNIA, Inc. Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.7.3 CAPNIA, Inc. Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 CAPNIA, Inc. Main Business Overview
13.7.5 CAPNIA, Inc. Latest Developments
13.8 碍颈产颈辞苍鈥嬧赌�
13.8.1 碍颈产颈辞苍鈥嬧赌� Company Information
13.8.2 碍颈产颈辞苍鈥嬧赌� Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.8.3 碍颈产颈辞苍鈥嬧赌� Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 碍颈产颈辞苍鈥嬧赌� Main Business Overview
13.8.5 碍颈产颈辞苍鈥嬧赌� Latest Developments
13.9 Otsuka Electronics
13.9.1 Otsuka Electronics Company Information
13.9.2 Otsuka Electronics Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.9.3 Otsuka Electronics Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Otsuka Electronics Main Business Overview
13.9.5 Otsuka Electronics Latest Developments
13.10 LEYI BIOLOGY
13.10.1 LEYI BIOLOGY Company Information
13.10.2 LEYI BIOLOGY Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.10.3 LEYI BIOLOGY Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 LEYI BIOLOGY Main Business Overview
13.10.5 LEYI BIOLOGY Latest Developments
13.11 Eco Physics AG
13.11.1 Eco Physics AG Company Information
13.11.2 Eco Physics AG Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.11.3 Eco Physics AG Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Eco Physics AG Main Business Overview
13.11.5 Eco Physics AG Latest Developments
13.12 Shenzhen Breax
13.12.1 Shenzhen Breax Company Information
13.12.2 Shenzhen Breax Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.12.3 Shenzhen Breax Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Shenzhen Breax Main Business Overview
13.12.5 Shenzhen Breax Latest Developments
13.13 QUINTRON
13.13.1 QUINTRON Company Information
13.13.2 QUINTRON Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.13.3 QUINTRON Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 QUINTRON Main Business Overview
13.13.5 QUINTRON Latest Developments
13.14 Beijing Wanliandaxinke Instruments Co
13.14.1 Beijing Wanliandaxinke Instruments Co Company Information
13.14.2 Beijing Wanliandaxinke Instruments Co Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.14.3 Beijing Wanliandaxinke Instruments Co Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Beijing Wanliandaxinke Instruments Co Main Business Overview
13.14.5 Beijing Wanliandaxinke Instruments Co Latest Developments
13.15 SIMES SIKMA
13.15.1 SIMES SIKMA Company Information
13.15.2 SIMES SIKMA Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.15.3 SIMES SIKMA Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 SIMES SIKMA Main Business Overview
13.15.5 SIMES SIKMA Latest Developments
13.16 Beijing Safe Heart Technology
13.16.1 Beijing Safe Heart Technology Company Information
13.16.2 Beijing Safe Heart Technology Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.16.3 Beijing Safe Heart Technology Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Beijing Safe Heart Technology Main Business Overview
13.16.5 Beijing Safe Heart Technology Latest Developments
13.17 e-LinkCare Meditech Co
13.17.1 e-LinkCare Meditech Co Company Information
13.17.2 e-LinkCare Meditech Co Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.17.3 e-LinkCare Meditech Co Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 e-LinkCare Meditech Co Main Business Overview
13.17.5 e-LinkCare Meditech Co Latest Developments
13.18 ChromX Health
13.18.1 ChromX Health Company Information
13.18.2 ChromX Health Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.18.3 ChromX Health Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 ChromX Health Main Business Overview
13.18.5 ChromX Health Latest Developments
13.19 Huiyuen Tech
13.19.1 Huiyuen Tech Company Information
13.19.2 Huiyuen Tech Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.19.3 Huiyuen Tech Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Huiyuen Tech Main Business Overview
13.19.5 Huiyuen Tech Latest Developments
13.20 Owlstone Medical
13.20.1 Owlstone Medical Company Information
13.20.2 Owlstone Medical Breath Molecular Diagnostic Device Product Portfolios and Specifications
13.20.3 Owlstone Medical Breath Molecular Diagnostic Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Owlstone Medical Main Business Overview
13.20.5 Owlstone Medical Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
